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Background: Work stress has become a major occupational risk factor in industrialized countries and an important
economic issue. The objective was to estimate the annual costs of coronary heart diseases (CHD) and mental
disorders (MD) attributable to job strain exposure according to Karasek’s model in France for the year 2003 from a
societal perspective.
Methods: We produced attributable fraction estimates which were applied to the number of cases (morbidity and
mortality) and the costs of CHD and MD. Relative risk estimates came from a systematic literature review of
prospective studies. We conducted meta-analyses based on this selection of studies. Prevalence of exposure to job
strain came from the national SUMER survey conducted in France in 2003. Costs included direct medical costs and
indirect costs: production losses due to sick leaves and premature deaths.
Results: Between 8.8 and 10.2% of CHD morbidity was attributable to job strain, and between 9.4 and 11.2% of
CHD mortality was attributable to this exposure for men. Between 15.2 and 19.8% of MD was attributable to job
strain for men, and between 14.3 and 27.1% for women. As a whole, between 450 000 and 590 000 cases of
diseases and 910–1130 deaths were attributable to job strain for men. From 730 000 to 1 380 000 cases of diseases
and from 150 to 280 deaths were attributable to job strain for women. The total number of sick leave days
amounted from 5 to 6.6 million days for men, and from 8.5 to 16 million days for women. The total costs of CHD
and MD attributable to job strain exposure ranged from 1.8 to 3 billion euros for the year 2003 (0.12-0.19% GDP).
Medical costs accounted for 11% of the total costs, value of life costs accounted for 13-15% and sick leave costs for
74-77%. The cost of CHD was estimated at 113–133 million euros and the cost of MD was between 1.7 - 2.8 billion
euros in 2003.
Conclusion: This study on the economic burden of diseases attributable to job strain in France provides relevant
insights for policy-makers when defining public health priorities for prevention policies.
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Work stress has become a major occupational risk factor
in all industrialized countries [1] and an important eco-
nomic issue. The high cost of work stress for employers,
social security systems and society as a whole has been em-
phasized in numerous studies [2-5] but detailed evaluations* Correspondence: sultan_taieb.helene@uqam.ca
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distribution, and reproduction in any mediumof these costs have been very seldom in the literature. A
few rough estimates were produced without explaining the
method used for such estimates. For example, costs of
work stress were estimated at €20 trillion in Europe per
year [6], but details on the estimation method were not
available. Moreover, the discrepancy between estimates can
be very large [7]. This is partly due to the fact that work
stress can be defined as a risk factor (related to working
conditions and work organization) or as a health outcome
related to mental disorders. For example, Hoel and al [8]
estimated that the costs of work stress and bullying mayntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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2000 in the UK (approx £4.9-34.1 billion), based on
the hypothesis that these risk factors represented 30%
of the overall cost of ill-health and accidents. The
Health and Safety Executive in the UK estimated the
cost of sickness absence due to stress, depression and
anxiety perceived by the worker as being ‘caused or
made worse by work’ (Labour Force Survey, UK) at
£530 million in 2006 [9].
A way to evaluate the cost of work stress is to measure
claims costs due to stress-related conditions at work.
But this type of evaluation depends on national legisla-
tive frameworks which vary from one country to an-
other. For example, in Australia, attempts have been
made to reduce the costs of stress-related claims by
modifying legislative thresholds on such claims [10]. In
general, occupational exposures costs based on workers
compensations only reflect a part of total costs, since oc-
cupational diseases or injuries have to be declared by
workers [11-13] and covered by social welfare or insur-
ance schemes to appear as claims [14].
Attributable fractions have been widely used in the lit-
erature to estimate the burden of diseases attributable to
occupational exposures in terms of morbidity or mortality
cases and disability-adjusted life years [15-20]. Attribut-
able fraction can also be used to estimate the monetary
cost of diseases attributable to occupational exposures but
literature remains very sparse on this issue, except for
some studies [21-23]. Studies are even less numerous
when considering the costs of disease attributable to expo-
sures to psychosocial risk factors at work [24-26]. How-
ever, precise and detailed economic evaluations of the
costs associated to psychosocial work exposures are much
needed to show the magnitude of the problem, and to
provide guidance to policy makers when defining public
health priorities and allocation of limited resources [27].
A large number of epidemiologic studies have shown
that exposure to work stress is a risk factor for various
health outcomes, especially cardiovascular diseases [28,29]
and mental disorders [30-32]. Less conclusive results have
been found for musculoskeletal diseases [33,34]. The lead-
ing work stress model in the literature is Karasek’s job
strain model [35]. This model is based on two dimensions:
psychological demands (i.e. job demands, time pressure,
conflicting demands, etc.), and decision latitude (i.e. both
control over work, named decision authority, and possibil-
ity of developing skills, named skill discretion). According
to this model, the most detrimental situation is defined by
the combination of high levels of psychological demands
and low levels of decision latitude, and is called job strain.
Data on the impact of job strain on workers’ health are
available in the literature and exposure to job strain has
been measured in a national survey, representative of the
working population, in France in 2003.The aim of this article was to estimate the costs of car-
diovascular diseases (CVD), and more precisely coronary
heart diseases (CHD) and mental disorders (MD), i.e. two
highly prevalent common mental disorders, depression
and anxiety, attributable to job strain exposure in France
in 2003 from a societal perspective, using a cost-of-illness
approach [36,37]. A societal perspective is used to take ac-
count of all the costs associated with a disease, no matter
who bears the costs, including health services and insur-
ances, patients and the production system (lost produc-
tion). This approach is considered as appropriate for
decision making concerning public health policies [38-40].
Methods
AF data and calculation
As defined by Nurminen and Karjalainen [19], attribut-
able fractions (AF) are an estimate of the fraction of
cases that is “attributable to an exposure in a population
and that would not have been observed if the exposure
had been non-existent”. AF calculations are based on
relative risk RR estimates (risks of disease or death due
to exposure to the risk factor) and prevalence of expos-
ure Pe estimates (proportion of the population exposed
to the risk factor) [41]:
AF ¼ Pe RR−1ð Þ= 1þ Pe RR−1ð Þð Þ ð1Þ
RR estimates were derived from a systematic literature
review of prospective studies published in peer-reviewed
journals between 1998 and 2008 (inclusive), i.e. a period
centered around the year 2003. Inclusion criteria were a
sufficient sample size (over 100 individuals) of a popula-
tion in industrialized countries, with an explicit use of
Karasek’s model for exposure assessment and a precise
measurement of health outcomes (clinically diagnosed
or based on validated instruments). Only studies study-
ing men and women separately and providing un-
adjusted (or age-adjusted) and multi-adjusted RRs/ORs
were retained. This literature review excluded studies
based on a job-exposure matrix known to underestimate
RRs [42]. Fifteen prospective studies were selected, more
details on the selection process of the literature review
are available elsewhere [34].
In order to summarize the results of this literature re-
view, we conducted meta-analyses based on this selec-
tion of studies. We retained 9 studies for CVD [43-51]
among which 8 produced RRs for CHD and 1 study
yielded RR estimates for CVD [46], i.e., for a broader
range of cardiovascular outcomes. We included 6 studies
for MD [52-57]. Depression and anxiety were evaluated
using either validated self-administered questionnaires,
such as the Beck Depression Inventory (BDI), Center for
Epidemiologic Studies Depression Scale (CES-D), General
Health Questionnaire (GHQ), and Psychiatric Symptom
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CIDI (Composite International Diagnostic Interview). We
calculated two sets of summary RR estimates separately
based (1) on unadjusted or age-adjusted RRs and (2) on
multi-adjusted RRs. We produced summary estimates for
men and women separately. We used a random effects
method with inverse variance weighting, which is consid-
ered as more conservative than the fixed effects method
[28,30]. Two indicators of heterogeneity between studies
were used: Cochran’s Q statistic with a p value <0.05 for a
significant heterogeneity and the I2 statistic [58]. We used
Stata software for meta-analysis calculations.
The data used for the estimate of prevalence of expos-
ure Pe to job strain came from the national SUMER sur-
vey which was conducted in France in 2003. This survey
is a periodical cross-sectional survey conducted by the
French Ministry of Labour (DARES) and including a self-
administered questionnaire, including Karasek’s Job Con-
tent Questionnaire (JCQ). In total, 24,486 employees,
12,241 men and 10,245 women, selected on a random
basis responded to the JCQ (response rate: 96.5%). The
data of the SUMER survey were weighted to provide esti-
mates that were representative of the French working
population. As a result, the 2003 SUMER survey provides
high quality data for exposure to job strain among the
French national working population according to gender
[42,59-62]. The estimates for the prevalence of job
strain exposure obtained from the SUMER survey were
19.6% for men, 28.2% for women, and 23.2% for the
total population.
We produced a range of attributable fraction (AF) values.
The AF low range value for each disease was calculated
using multi-adjusted RR summary estimates in formula (1)
and the AF high range value was based on age-adjusted RR
summary estimates. In this calculation, we assumed that
ORs were satisfactory estimates for RRs, which allowed to
use ORs for AFs calculation in formula (1).
We computed confidence intervals at 95%, based on
100 000 simulated distributions of Pe and RR, with the
hypothesis that RR and Pe follow independent normal
distributions. Confidence intervals were calculated with
the mean and standard deviation from the simulated
values of AFs. We used SAS software for simulation
calculations.
Data on prevalence of diseases
We considered all national surveys available in France
for the number of cases (morbidity and mortality) of
CVD and MD. Inclusion criteria were a definition of dis-
ease corresponding to health outcomes used in our sum-
mary RR estimates, the availability of data for men and
women separately, the availability of data for working-
age population, and the survey had to be conducted in
2003 or as close as possible to 2003.CHD morbidity data
Since most of the selected studies for CVD produced
RRs for CHD (8 studies out of 9), we retained prevalence
and costs data on CHD rather than CVD to ensure
consistency between data used in our estimation. We
used the prevalence of CHD (CIM 10, codes I20-I25)
from the database of the Health and Social Benefits Sur-
vey (Enquête Santé et Protection Sociale) conducted in
France in 2004 by IRDES (Institut de Recherche et
Documentation en Économie de la Santé). Weighted
prevalence data were computed and provided by IRDES
for men (1.38%) and women (0.37%) from 18 to 64 years.
We assumed a stable prevalence of CHD between 2003
and 2004 in France.
CHD mortality data
We used mortality data in 2003 from the database of the
Epidemiological Center for the Medical Causes of Death
(Centre d’Épidémiologie sur les Causes Médicales de
Décès, CEPIDC) [63]. It provides the number of deaths
from CHD (CIM 10, codes I20-I25) for men and women
from 20 to 64 years.
MD morbidity data
We computed the prevalence of MD (depression and
anxiety) from a French national survey, the Ten-yearly
Health survey 2002–2003 (Enquête Décennale Santé).
Data were weighted by age and gender. MD were de-
fined by a score obtained to CES-D equal or higher than
16. The prevalence of MD for the population from 18 to
64 years was 15.5% (95% confidence interval: 14.6%-
16.4%) for men and 27.4% (95% confidence interval:
26.4%- 28.4%) for women in France.
MD mortality data
We used data about the prevalence of suicide in 2003
provided by the Epidemiological Center for the Medical
Causes of Death (Centre d’Épidémiologie sur les Causes
Médicales de Décès, CEPIDC) for men and women from
20 to 64 years [63]. Based on an analysis of the literature
[64-66], we assumed that from 54 to 64% of suicides were
due to depression. A sensitivity analysis was conducted to
take account of these two percentages.
Another sensitivity analysis was conducted using a
more restrictive definition of mental disorders based on
depression alone. For this analysis, we used depression
morbidity data produced by ESEMED study (European
Study of the Epidemiology of Mental disorders) which was
based on a standardized diagnostic interview (WMH-
CIDI: World Mental Health- Composite International
Diagnostic Interview). According to this survey, the preva-
lence of depression was 4.7% (95% confidence interval:
3.6%-5.8%) for men and 8.5% (95% confidence interval:
7.1%-9.9%) for women in France [67]. We computed AF
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provided by Shields’s [57] study. It was the only study in
our literature review based on a measure of depression
using a standardized diagnostic interview (CIDI) and pro-
ducing both crude and multi-adjusted RR estimates.
Cost data and calculation
Costs C were estimated from a societal perspective
according to a prevalence approach and based on French
data. They included medical costs M of CHD and MD
and indirect costs: production losses due to sick leaves S
and to premature deaths D attributable to job strain ex-




Mi þ Si þ Dið ÞAFi ð2Þ
where AFi is the attributable fraction corresponding to
disease i (CHD or MD). Data on production losses due
to early retirement and to presenteeism were not avail-
able. For the data on medical and indirect costs of dis-
eases we conducted a systematic review of French and
international databases, reports (EUROHEED-CODECS,
DREES, IRDES, CNAMTS, Base BDSP, OECD, WHO)
and articles published in peer reviewed journals through
Medline interrogations.
Indirect costs were calculated on the basis of the hu-
man capital hypothesis [68], by multiplying the number
of lost days because of illness with the Gross Domestic
Product per capita and per working day (GDPcd) for the
year 2003 in France. The value of production losses due
to premature death is estimated to take account of the
lost production due to the number of years lost between
the age of death and the average retirement age, as











Where VLY is the value of lost years of production
due to disease (CHD or MD), GDPcd is the French Gross
Domestic Product per capita and per working day, Na is
the number of deaths due to the disease at the age a in
the French population, R-a is the number of years lost
between the age of death a and the average retirement
age R, g is the annual growth rate of GDP and r the dis-
count rate. A discount rate of 5% and a growth rate of
2% were posited, as generally assumed.
A sensitivity analysis was conducted to take account of
the two range values for the number of suicides due to
depression in the literature (54% or 64%) and the two
values of attributable fractions which we computed
(from multi or age-adjusted RRs).CHD medical costs
According to Paris and al [69], CHD represented 16% of
national consumption of medical care and goods for dis-
eases of the circulatory system in France in 1998. And
according to Fenina and al [70], diseases of the circula-
tory system represented 12.6% of the total consumption
of medical care and goods in France in 2002. We as-
sumed that average medical expenses for each case of
CHD were the same between genders and age groups
and a stable proportion of CHD medical expenses in
total consumption of medical care and goods from 1998
to 2003 in France.
CHD indirect costs
Statistics from the public medical care system provided
the number of sick leave days as prescribed by cardiolo-
gists in France in 2003 [71]. We made the assumption
that the distribution of sick leave days between men and
women was similar to the distribution of CHD cases be-
tween genders.
MD medical costs
According to Paris and al [69], depression represented
1.05% of the total consumption of medical care and
goods in France in 1998. We assumed that medical ex-
penses for each case of MD were the same between gen-
ders and age groups and a stable proportion of MD
medical expenses in total consumption of medical care
and goods from 1998 to 2003.
MD indirect costs
A study by Morvan et al. [72], on the basis of a national
survey conducted in France in 2005 (Baromètre Santé
2005), produced the proportion of mild, average and se-
vere episodes of depression in the population suffering
from depression and the corresponding number of sick
leave days per year. According to this survey, 17.8% of
persons suffering from mild depressive episodes take an
average of 10.4 sick leave days per year. 26.2% of persons
suffering from average depressive episodes take an aver-
age of 49.2 sick leave days per year. And 48.9% of per-
sons suffering from major depressive episodes take an
average of 108.1 sick leave days per year. We assumed
that the distribution of sick leave days between men and
women was similar to the distribution of depression
cases between genders. We also assumed that the num-
ber of sick leave days was stable between 2003 and 2005.
Health reasons for sick leaves are not available in health
insurance databases in France because the medical cause
of absence is covered by confidentiality.
Results
Meta-analysis results are shown in Figure 1. Summary
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Job strain and mental disorders among women, multi-adjusted odds-
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Job strain and mental disorders among women, age-adjusted or 
unadjusted odds-ratio (Heterogeneity : Q=13.4, d.f.=3, p=0.004 ; 
I2=77.6%)
Figure 1 Meta-analysis.
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and 1.04. Significant summary RRs for CHD mortality
were 1.53 and 1.64 for men. There was no multi-adjusted
RR for CHD mortality among women and only one non-
significant age-adjusted RR estimate. Thus available data
did not allow the calculation of summary RR estimates for
CHD mortality among women. Summary OR estimates
for MD were significant for both genders, 1.92 and 2.26
for men, 1.59 and 2.32 for women. Summary RR and OR
estimates and 95% confidence intervals are shown in
Table 1.
For men, 8.8-10.2% of CHD morbidity was attributable
to job strain. Attributable fractions (AF) for CHD mor-
tality were 9.4-11.2% for men. AFs for CHD morbidity
and mortality for women yielded non significant values
(Table 2). Therefore, we could not infer the burden of
CHD attributable to job strain exposure for women, for
lack of significant RR data. Between 15.2 and 19.8% of
MD were attributable to job strain for men, and between
14.3 and 27.1% for women, these two AFs being signifi-
cant. AF estimates and 95% confidence intervals are
shown in Table 2.
Between 22 071 and 25 743 cases of CHD were attrib-
utable to job strain exposure, and between 442 and 524
deaths among men. For MD, between 430 470 and 559
215 cases for men and 727 266–1 378 718 cases for
women were attributable to job strain exposure. Between
619 and 894 deaths (suicides associated with depression)
for men and women were attributable to this exposure.
The number of sick leave days lost because of CHD at-
tributable to job strain went from 55 015 to 64 167 days.
For MD, the number of lost working days amounted
from 5 016 529 to 6 516 864 days for men and from 8
475 264 to 16 067 034 days for women (Table 3).
The total costs of CHD and MD attributable to job
strain exposure ranged from approximately 1.8 to 3 bil-
lion euros per year in France. This cost included medical
costs, the value of sick leave days lost because of disease,
and the value of life years lost because of premature
death. The cost of CHD was estimated at 113–133 mil-
lion euros. The cost of MD was around 1.7 and 2.8 bil-
lion euros. Results are shown in Table 4.Table 1 Summary relative risks (RR) and odds-ratios (OR) on t
diseases (CHD) and mental disorders (MD)
CHD
Morbidity RR 95% CI Morta
Men M-A 1.49 1.18 1.89 1.
A-A 1.58 1.29 1.94 1.
Women M-A 1.01 0.62 1.63
A-A 1.04 0.45 2.41 1.0
M-A: multi-adjusted, A-A: age-adjusted or unadjusted.
* Estimate from one study only (Lee et al., [48]), not a summary RR.
95% CI : confidence interval at 95%.We computed a sensitivity analysis based on a less
conservative hypothesis for the percentage of suicides
associated with depression, according to data available in
the literature [64-66]. Assuming that 64% of suicides
were associated with depression instead of 54%, the
number of deaths related to MD attributable to job
strain was between 556 and 723 for men, and between
178 and 337 for women. As a result, the total number of
deaths increased by 18.5% and the total costs increased
by around 2%. Therefore, this alternative hypothesis had
a limited impact on the total costs attributable to job
strain exposure.
We also conducted a more conservative analysis based
on a restrictive definition of mental disorders, including
depression only. RR estimates for depression were de-
rived from Shields’s study [57] and were from 2.9 to 3.3
for men and from 1.2 to 2 for women, with a non-
significant multi-adjusted RR estimate for women. Thus,
available data did not allow the calculation of AF based
on multi-adjusted RR estimate for women. For men,
27.2-31.1% of depression was attributable to job strain
and 22% for women. Between 232 308 and 266 007 cases
of depression for men and 346 172 cases of depression
for women were attributable to job strain exposure. The
number of lost working days because of depression at-
tributable to job strain amounted from 2 707 220 to 7
134 095 days for men and women. The cost of depres-
sion attributable to job strain was between 780 million
and 1.6 billion euros.
Discussion
Between 8.8 and 10.2% of CHD morbidity was attribut-
able to job strain, and between 9.4 and 11.2% of CHD
mortality was attributable to this exposure for men. Be-
tween 15.2 and 19.8% of MD (depression and anxiety)
was attributable to job strain for men, between 14.3 and
27.1% for women. As a whole, between 450 000 and 590
000 cases of diseases and 910–1130 deaths were attribut-
able to job strain for men. From 730 000 to 1 380 000
cases of diseases and from 150 to 280 deaths were attrib-
utable to job strain for women. The number of deaths
attributable to job strain is approximately twice thehe association between job strain and coronary heart
MD
lity RR 95% CI Morbidity OR 95% CI
53 1.19 1.98 1.92 1.52 2.41
64 1.28 2.10 2.26 1.66 3.08
/ 1.59 1.32 1.93
9* 0.4 2.92 2.32 1.55 3.47
Table 2 Fractions of coronary heart diseases (CHD) and mental disorders (MD) attributable to job strain in France (%)
CHD MD
Morbidity 95% CI Mortality 95% CI Morbidity 95% CI Mortality 95% CI
Men M-A 8.8 3.2 14.7 9.4 3.3 15.9 15.2 9.0 21.5 15.2 9.0 21.5
A-A 10.2 5.2 15.4 11.2 4.9 17.5 19.8 11.1 28.7 19.8 11.1 28.7
Women M-A 0.2 −13.1 14.1 / 14.3 8.1 20.7 14.3 8.1 20.7
A-A 1.1 −21.6 25.9 2.5 −24.7 31.9 27.1 13.2 41.0 27.1 13.2 41.0
M-A: attributable fraction based on multi-adjusted relative risk, A-A: attributable fraction based on age-adjusted or unadjusted relative risk.
95% CI: confidence interval at 95%.
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in 2003. The total number of sick leave days for the year
2003 amounted from 5 to 6.6 million days for men, and
from 8.5 to 16 million days for women. The total costs
of CHD and MD attributable to job strain exposure
ranged from approximately 1.8 to 3 billion euros for the
year 2003 in France (0.12-0.19% GDP). Medical costs
accounted for 11% of the total costs, value of life costs
accounted for 13-15% and sick leave costs for 74-77%.
The cost of CHD was estimated at 113–133 million
euros and the cost of MD was between 1.7 and 2.8 bil-
lion euros. Thus MD accounted for approximately 94-
96% of the total costs attributable to job strain exposure.
This is due to a higher prevalence of the disease among
the population of working age, higher levels of attribut-
able fractions, and also a high amount of sick leave days
due to MD. The sensitivity analysis conducted on a
more restrictive definition of mental disorders including
depression only, produced much lower values in terms
of number of cases and costs. This calculation can be
considered as very conservative. Indeed, the definition of
mental disorders was restricted to clinical depression,
and thus excluded anxiety but also symptomatic cases of
depression and anxiety. Furthermore, the RR estimates
were based on only one available prospective study that
produced RR estimates using a standardized diagnostic




CHD morbidity 22 071 25 743
CHD mortality 442 524
MD morbidity 430 470 559 215
MD mortality 469 610
Number of sick leave days for CHD 55 015 64 167
Number of sick leave days for MD 5 016 529 6 516 864
Total number of cases 452 542 584 957
Total number of deaths 912 1 134
Total number of sick leave days 5 071 545 6 581 031multi-adjusted RR estimates for women, which did not
allow to calculate a low range value of AF estimates.
Some limitations of the study must be pointed out.
This estimate of the cost of diseases attributable to job
strain exposure may be more under-estimated than
over-estimated. We did not produce AF estimates of
CHD morbidity and mortality for women since available
data were very scarce and the rare included studies
yielded non-significant RRs. Therefore the estimation of
the cost of CHD attributable to job strain was provided
for men only. Another way of interpreting the results
may be that our estimates of costs may be null for
women, something that may be a bit premature to con-
clude given the scarcity of the literature. Indeed, recent
studies show an increase in CVD prevalence among
women in the French population [73,74], which underlines
the need for more investigations on the etiological role of
job strain on CVD among women. The estimates did not
take account of potential delayed effects of job strain ex-
posure on cardiovascular or mental health. We included
only CHD and MD in our study. The number of studies
selected in our literature review was very small for muscu-
loskeletal disorders (MSD) and concerned different loca-
tions (back, low back, neck, shoulder, upper extremity,
elbow, hand, and wrist) [34]. Therefore we could not com-
pute a summary OR and AF estimates for a specific MSD
location which could be used for cost of illness estimates.disorders (MD) imputable to job strain exposure in
Women Total
Multi-adjusted Age-adjusted Multi-adjusted Age-adjusted
- - 22 071 25 743
- - 442 524
727 266 1 378 718 1 157 736 1 937 933
150 284 619 894
- - 55 015 64 167
8 475 264 16 067 034 13 491 794 22 583 898
727 266 1 378 718 1 179 807 1 963 676
150 284 1 062 1 418
8 475 264 16 067 034 13 546 809 22 648 065
Table 4 Costs of diseases imputable to job strain en France in 2003 (euros)
Men Women Total
Multi-adjusted Age-adjusted Multi-adjusted Age-adjusted Multi-adjusted Age-adjusted
CHD
Medical costs 41 107 656 47 945 576 41 107 656 47 945 576
Sick leave costs 5 543 673 6 465 817 5 543 673 6 465 817
Value of life costs 66 565 007 78 813 896 66 565 007 78 813 896
Total CHD 113 216 336 133 225 290 - - 113 216 336 133 225 290
MD
Medical costs 60 368 981 78 424 030 101 991 441 193 350 898 162 360 422 271 774 928
Sick leave costs 505 494 140 656 676 437 854 015 999 1 619 006 057 1 359 510 139 2 275 682 494
Value of life costs 156 839 921 203 747 328 47 243 181 89 561 550 204 083 102 293 308 877
Total MD 722 703 042 938 847 795 1 003 250 621 1 901 918 505 1 725 953 663 2 840 766 300
Total 835 919 378 1 072 073 084 1 003 250 621 1 901 918 505 1 839 170 000 2 973 991 589
CHD: coronary heart diseases, MD: mental disorders.
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attributable to work stress since job strain is only one as-
pect of stress among other concepts, such as Effort-Reward
Imbalance developed by Siegrist [75]. Cost data had also
some limitations. Costs did not include production losses
due to presenteeism and to early retirement for lack of
data. Other cost categories could not be included in our es-
timates, such as the costs of informal care (provided by
families and friends), intangible costs (cost of suffering,
pain and discomfort) and the cost of job turnover for lack
of data. We also limited the value of lost years of life to the
value of lost production. We did not take account of the
total losses of social welfare due to deaths through an esti-
mation of willingness to pay or value of a statistical life for
instance, for lack of available data. For all these reasons,
our estimates can be considered as conservative. In
addition, we made a number of assumptions in our calcu-
lations and these assumptions may not be verified easily.
For example, we assumed that the RR of mental disorders
associated with job strain was the same for morbidity and
mortality, something that may be consistent for cardiovas-
cular diseases but was not checked for mental disorders,
the literature being rare on this topic [76]. Another ex-
ample, the proportion of suicides due to depression was es-
timated to be 54%-64% of the total number of suicides in
the general population but it was not possible to check
whether these figures may be used for the working
population.
This study has also several strengths. Our meta-
analyses for RR estimates showed a satisfactory homo-
geneity between studies, except for age-adjusted ORs of
MD for women which yielded a significant level of het-
erogeneity. Overall, the risk of heterogeneity between
studies was mitigated by the fact that we included only
high quality studies in our systematic review of the litera-
ture, with similar exposure and with statistical analysesallowing the estimation of RRs. The data we used are
highly consistent: RR, prevalence of exposure, prevalence
of disease and cost data are based on the same definition
of disease and exposure. To ensure such consistency, we
conducted a systematic review of the literature for disease
prevalence and costs data in France and we produced data
for each gender separately. The only exception may be the
use of mental disorders medical costs based on the med-
ical cost of depression only that may underestimate the
costs of mental disorders attributable to job strain. We
performed a sensibility analysis including depression only
to provide a very conservative estimate of mental disor-
ders costs attributable to job strain. The medical costs
used in our study included out-of pocket payments by pa-
tients along with medical expenses paid by insurances,
which is well appropriate for estimations from a societal
perspective. We produced two range values of AF esti-
mates with confidence intervals, based on a meta-analysis
of RRs. Our calculation method had several strengths: we
took account of multi-adjusted and age-adjusted estimates
in our calculations, which produced the AF range values.
And we combined this approach to meta-analyses to get
more precise estimates of AFs based on available data in
the literature. This method allowed us to encompass vari-
ous high-quality RR estimates in our summary RRs, and at
the same time to take account of a certain level of uncer-
tainty regarding RRs, since age-adjusted and multi-
adjusted estimates yielded different values.
Our summary RRs for CVD are consistent with those
from the meta-analysis by Kivimaki et al. [28] providing
a summary age and gender-adjusted RR of 1.45 (95% CI:
1.15-1.84) and a multi-adjusted RR of 1.16 (95% CI:
0.94-1.43). Our RR estimates regarding men are higher,
but this difference could be explained by the fact that
Kivimaki et al’s estimates included both men and
women. Our results for MD are also consistent with
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Candy [30] (summary OR: 1.82, 95% CI: 1.06-3.10). Our
estimates of attributable fractions for CVD mortality are
more conservative than those reported by Nurminen &
Karjalainen [19], who found estimates of 16% for men
for the fractions of cardiovascular deaths attributable to
job strain in Finland. Our AF estimates for MD are in
line with those of LaMontagne et al. [77] who reported
fractions of 13.2% for men and 17.2% for women attrib-
utable to job strain in Australia. Their fractions resulted
from the summary OR estimates from Stansfeld and
Candy’s meta-analysis [30]. Our results are higher than
the costs of diseases attributable to job strain exposure
in a previous study by Béjean et Sultan-Taïeb [25]. For
the year 2000 in France, total costs amounted for 1.2-1.6
billion euros but included also musculoskeletal disorders.
Differences can be explained by the fact that the fractions
of MD for women were underestimated (4.8%) since they
were based on a limited selection of OR estimates in the
literature. The cost of depression attributable to job strain
in Australia was estimated by LaMontagne et al. [26] at
730 million dollars AUD (approx.. 510 million euros) in
2007, given that 1.54 million persons suffer from depres-
sion in the Australian workforce. It is however difficult to
compare these results with ours since categories of costs
included in the estimations are different: job turnover and
presenteeism costs are included in LaMontagne et al.’s
study, while indirect costs related to premature death
(suicide) are excluded.
Our results provide an evaluation at one point of time,
allowing projections of the cost of job strain according to
the evolution of working environments and the trend of
prevalence of exposure to job strain. It also allows com-
parisons with other countries. Our summary estimates of
RRs for CHD and MD could be used for AF calculations
in other countries where the prevalence of exposure to job
strain has been measured in the working population.
Conclusions
This study on the economic burden of diseases attribut-
able to job strain in France provides relevant insights for
policy-makers when defining public health priorities for
prevention policies. Diseases attributable to job strain
and related costs are avoidable since effective interven-
tion strategies to prevent job stress have been identified
in several literature reviews [78-80]. Our results high-
light potential economic implications of the develop-
ment of such prevention policies.
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